Abstract
The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 10010 |
Tidsskrift | Scientific Reports |
Vol/bind | 8 |
Udgave nummer | 1 |
Sider (fra-til) | 1-18 |
ISSN | 2045-2322 |
DOI | |
Status | Udgivet - 2018 |